CS logo
small CS logo
CTC Sahlgrenska Universitetssjukhuset

Goteborg, Sweden
Sjukhus i Göteborg

About CTC Sahlgrenska Universitetssjukhuset


Sahlgrenska Universitetssjukhuset är Sveriges största sjukhus och ett av de större i norra Europa. Verksamheten hade en omsättning på 19,4 miljarder kronor 2021. Sjukhuset bildades den 1 januari 1997 när akutsjukhusen Sahlgrenska sjukhuset, Östra sjukhuset och Mölndals sjukhus slogs ihop.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Boehringer Ingelheim
4
Imcyse SA
2
Pfizer
2
Scandinavian Biopharma AB
1
Total Rows: 4

Clinical Trials at CTC Sahlgrenska Universitetssjukhuset


During the past decade, CTC Sahlgrenska Universitetssjukhuset conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 5 clinical trials were completed, i.e. on average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1100220011002200001122001100Started TrialsCompleted Trails20152016201720182019202020210123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes
2010-11-11
2018-08-21
Completed
6,103
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-03-22
Terminated
16,784
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
2014-10-28
2017-07-10
Completed
746
Empagliflozin as Adjunctive to Insulin Therapy Over 26 Weeks in Patients With T1DM (EASE-3)
2015-12-22
2017-09-20
Completed
977
This International Study Tests BI 690517 in Patients With Diabetic Kidney Disease. The Study Tests How 3 Different Doses of BI 690517 Are Taken up in the Body and How Well They Are Tolerated
2017-10-05
2020-05-07
Completed
62
Study of IMCY-0098 in Patients With Recent Onset Type 1 Diabetes
2017-08-23
2019-08-30
Completed
41
IMCY-T1D-002: Long-term Follow-up Study of T1D Patients Previously Treated With IMCY-0098 or Placebo
2019-02-14
2019-11-18
Completed
30
A Study to Test the Effect of Different Doses of BI 685509 on Kidney Function in People With Chronic Kidney Disease
2021-04-27
2023-09-30
Recruiting
240

Rows per page:

1–9 of 9

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "CTC Sahlgrenska Universitetssjukhuset" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Göteborg University" with 1 trials as a collaborator, "Sahlgrenska University Hospital, Sweden" with 1 trials as a collaborator and "Scandinavian CRO" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.
Created with Highcharts 11.1.0Top Leading SponsorsBoehringer Ingelheim: 4Boehringer Ingelheim: 4Imcyse SA: 2Imcyse SA: 2Pfizer: 2Pfizer: 2Scandinavian Biopharma AB: 1Scandinavian Biopharma AB: 1

Created with Highcharts 11.1.0Top CollaboratorsEli Lilly and Company: 2Eli Lilly and Company: 2Göteborg University: 1Göteborg University: 1Sahlgrenska UniversityHospital, Sweden: 1Sahlgrenska UniversityHospital, Sweden: 1Scandinavian CRO: 1Scandinavian CRO: 1

Clinical Trials Conditions at CTC Sahlgrenska Universitetssjukhuset


According to Clinical.Site data, the most researched conditions in "CTC Sahlgrenska Universitetssjukhuset" are "Type 1 Diabetes Mellitus" (2 trials), "Cardiovascular Disease" (1 trials), "Chronic Kidney Disease" (1 trials), "Diabetes Mellitus, Type 1" (1 trials) and "Diabetes Mellitus, Type 2" (1 trials). Many other conditions were trialed in "CTC Sahlgrenska Universitetssjukhuset" in a lesser frequency.

Clinical Trials Intervention Types at CTC Sahlgrenska Universitetssjukhuset


Most popular intervention types in "CTC Sahlgrenska Universitetssjukhuset" are "Drug" (8 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "BI 685509" (1 trials), "BI 690517" (1 trials), "Bococizumab (PF-04950615; RN316)" (1 trials) and "Empagliflozin" (1 trials). Other intervention names were less common.

Clinical Trials Genders at CTC Sahlgrenska Universitetssjukhuset


The vast majority of trials in "CTC Sahlgrenska Universitetssjukhuset" are 9 trials for "All" genders.

Clinical Trials Status at CTC Sahlgrenska Universitetssjukhuset


Currently, there are NaN active trials in "CTC Sahlgrenska Universitetssjukhuset". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in CTC Sahlgrenska Universitetssjukhuset, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in CTC Sahlgrenska Universitetssjukhuset, 3 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 4Phase 3: 4Phase 1: 3Phase 1: 3Phase 2: 2Phase 2: 2

Created with Highcharts 11.1.0Trials StatusCompleted: 7Completed: 7Recruiting: 1Recruiting: 1Terminated: 1Terminated: 1